GPT and hepatocellular carcinoma: DOX-AuNPs significantly decreased ALT, AST, ALP, GGT and bilirubin by 77.86%, 54.75%, 45.09%, 55.68% and 57.16% (p < 0.001), respectively, compared to HCC.